Yayıncı "Imprimatur Publication" PubMed İndeksli Yayınlar Koleksiyonu için listeleme
Toplam kayıt 1, listelenen: 1-1
-
Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey
(Imprimatur Publication, 2020)Purpose: After failure of the first-line sorafenib treatment in advanced or metastatic stage hepatocellular carcinoma (HCC), regorafenib is one of the newly-approved targeted agents. We aimed to evaluate the efficacy of ...